BridgeBio has demonstrably advanced the progress of a novel therapy for ATTR-CM, employing Attruby. Initial clinical results reveals potential outcomes for individuals diagnosed from the debilitating disease. This focus underscores researchers’ dedication to treating significant medical needs in the heart field. Attruby: BridgeBio's Nov… Read More